1/2-Dopaminergic Dysfunction in Late-Life Depression (The D3 Study)

Clinical trial NCT04493320 · TERMINATED

Trial details

NCT number: NCT04493320
Sponsor: New York State Psychiatric Institute
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Depression Cognitive Impairment Gait Impairment

Start date: 2021-02-10
Primary completion: 2021-10-27
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.